SAMIL PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 000520 for the last quarter is 54.29 B KRW, and it's 0.02% lower compared to the previous quarter. The net income of Q2 24 is 350.31 M KRW.